Community Schedule

Enter at least 4 characters

1 results showing for: 'imatinib mesilate'

  1. Protein-tyrosine Kinase Inhibitors
Imatinib mesilate    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 169.
  • Tab 100 mg [Xpharm] - Special Authority SA1460
    • Brand Fully subsidised brand. Glivec
    • Pharmacode2123606
    • Subsidy $2400.00
    • Measure / Qty per 60
    SA1460 – Imatinib mesylate (Glivec) for treatment of gastrointestinal stromal tumour (GIST)
  • 3 to 6 month supply. Cap 100 mg
    • Brand Fully subsidised brand. Imatinib-Rex
    • Pharmacode2594315
    • Subsidy $58.23
    • Measure / Qty per 60
  • 3 to 6 month supply. Cap 400 mg
    • Brand Fully subsidised brand. Imatinib-Rex
    • Pharmacode2594323
    • Subsidy $84.79
    • Measure / Qty per 30

Note: The Glivec brand of imatinib mesilate (supplied by Novartis) remains fully subsidised under Special Authority for patients with unresectable and/or metastatic malignant GIST only, see SA1460 in Section B of the Pharmaceutical Schedule.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply



Email enquiry@pharmac.govt.nz to provide feedback: compliments, suggestions and complaints.